Impact of the COVID-19 Pandemic on Utilization and Cost for Care of Pediatric ALL
Description
Objective Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy and requires a unique pattern of healthcare utilization including an acute/emergent presentation and an intensive initial 8 months of therapy followed by two years
